logo

COYA

Coya Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.49 / 10
Netural

Fund-flow analysis shows a good score (7.61/10) with a positive small-cap inflow trend (0.5037), but block and medium/large flows are negative, indicating institutional hesitation. Analyst coverage is limited to two providers, both issuing Strong Buy ratings, yet their historical win rates are low (25-31.6%), tempering conviction. The neutral sentiment score (5.49/10) reflects this balance between optimistic ratings and mixed flow dynamics.

FundamentalSentiment(5.49)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-01-21
InstitutionD. Boral Capital
Times predicted19
Historical Win Rate31.6%
What is the analyst consensus for COYA?
  • COYA holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.49/10 (Netural).